Solid Biosciences Inc. (SLDB) › Capital ExpendituresSolid Biosciences Inc. (SLDB) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2016: $392.0K2017: $2.28M2018: $7.78M2019: $4.39M2020: $899.0K2021: $1.28M2022: $3.02M2023: $1.51M2024: $654.0K2025: $1.15M$1.15M2016Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$1.15M+76.3%2024$654.0K-56.8%2023$1.51M-49.8%2022$3.02M+135.4%2021$1.28M+42.5%2020$899.0K-79.5%2019$4.39M-43.6%2018$7.78M+241.7%2017$2.28M+480.6%2016$392.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share